Company Announcements

Publication of Supplementary Prospectus

Source: RNS
RNS Number : 4965P
British American Tobacco PLC
09 February 2023

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplementary Prospectus dated 9 February 2023 (the "Supplementary Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of B.A.T. International Finance p.l.c., B.A.T Capital Corporation and B.A.T. Netherlands Finance B.V. (as Issuers) and British American Tobacco p.l.c. and each of the Issuers (except where it is the relevant Issuer) (as Guarantors).

The Supplementary Prospectus should be read and construed in conjunction with the Base Prospectus dated 17 March 2022, as supplemented by the supplementary prospectus dated 8 August 2022 (together, the "Prospectus").

To view the Supplementary Prospectus, and the documents incorporated by reference therein, please paste the following URL into the address bar of your browser.

The full documents have been submitted to the National Storage Mechanism and will shortly be available for inspection at


British American Tobacco Media Centre
+44 (0)20 7845 2888 (24 hours) │@BATPlc


Investor Relations
Victoria Buxton / Yetunde Ibe / John Harney:
+44 (0)20 7845 2012 / 1095 / 1263


British American Tobacco p.l.c.
Globe House
4 Temple Place
London WC2R 2PG


Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.